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Abstract
Background: Starfruit (Averrhoa carambola) leaves contain flavone derivatives that exhibit anti-hyperglycemic
effects. This study aims to determine the effect of starfruit leaves in reducing glucose absorption in intestinal epithelial
cells of mice. Methods: This study was done by performing perfusion on the small intestines of mice. The mice that
were used in this study were divided into four groups. The control group was given glucose solution without infused
starfruit leaves whereas, the remaining 3 groups were given 3 mmol (540 mg/dL) glucose solution with infused starfruit
leaves of varying concentrations; 200, 400, and 600 mg/kg. Samples were collected at 0, 15th, 30th, 45th, and 60th minute.
The sample was tested for glucose levels using spectrophotometry. Results: Test of significance showed a significant
difference between the control group and the test group with p < 0.05. Conclusions: Starfruit leaves have a reduction
effect towards glucose absorption in the small intestines in Wistar strains where the group using 600 mg/kg of infused
starfruit leaves have the most significant effect as compared to other groups.
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mechanism of starfruit leaves in lowering the blood
glucose level is still exactly unknown. However, on
previous study conclude that starfruit’s leaves infusion

Introduction
Studies about the usage of herbal based medicine to cure
diseases has been done, including to decrease the blood
glucose level.1 Previously known that the mechanism of
glucose absorption can occur in a few ways; from glucose
diffusion and protein transport. There are two type in
glucose’s protein transport mechanism; Sodium-Glucose
Transport Proteins (SGLT1) and Glucose Transporter 2
(GLUT2).2-4 The mechanism of decreasing blood
glucose could occur in a few ways. The fibers that are in
herbal substances could inhibit glucose absorption.5-11
Fibers are complicated to dissolve to smaller molecule
because human’s intestine is lack of enzyme that can
dissolve the fibers. Hence, the monosaccharides that
bond with the fiber are difficult to absorb in human’s
intestine.11 Aside from that, there are certain active
substances that have glucose inhibition activity in the
intestinal epithelial cells.12,13

Figure 1. Apigenin-6-C-β-L-fucopyranoside1

Starfruit leaves has flavone derivatives in the form of
apigenin-6-C-β-L-fucopyranoside (Figure 1) and apigenin6-C-(2-O-α-L-rhamnopyranosyl)-β-1-fucopyranoside
(Figure 2) that has a potential of anti-hyperglycemic
effect.1,14,15 Even though it is known that starfruit leaves
exhibits an anti-hyperglycemic effect, the molecular

Figure 2. Apigenin-6-C-(2-O-α-L-rhamnopyranosyl)-β-1fucopyranoside1
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had effect on activity of glucose transportation on small
intestine; apigenin-6-C-β-L-fucopyranoside and apigenin6-C-(2-O-α-L-rhamnopyranosyl)-β-1-fucopyranoside
activate Phosphoinositide 3-Kinase inhibitor (PI3K
inhibitor), Protein Kinase C inhibitor (PKC inhibitor),
and Mitogen-activated Protein Kinase inhibitor (MEK
inhibitor) to involve the glucose absorption activity.1
Hence, this study has a purpose to observe the effect of
infused starfruit leaves on glucose transport in the
intestinal epithelial cells of mice.

In this experiment, the researcher need to take notice the
ethical aspect of animal experiment. In reduction aspect,
researcher has used Federer’s formula to acquire the
smallest population samples on each group. In refinement
aspect, researcher has provided proper mice’s shelter
and provision of food and water on adaptation phase.
On data collection phase, researcher has used ketamine
as anesthetic agent to relieve the mice from pain. And in
replacement aspect, researcher has decided to use mice
as population sample in order to use the lower animal
levels.

Methods
Results
This study was done in November 2015 in the
Biochemistry Laboratory, Faculty of Medicine, Universitas
Padjadjaran. The starfruit leaves were obtained from the
Sekolah Ilmu Teknologi Hayati, Bandung Institute of
Technology. The leaves were dried and infused using
leaves that weighed 20, 40, and 60 g to produce
sequential infusions with concentrations of 200, 400 and
600 mg/kg of the mice weight. Each of the infused
starfruit leaves was then mixed with 3mmol glucose
solution with a ratio of 1:24 for the mice group that was
given an infusion. Meanwhile, the control group was
given distilled water (aqua dest) and 3 mmol glucose
solution with the same ratio. For all subject enrolled in
this study was approved by research ethics committee
from Faculty of Medicine Universitas Padjadjaran with
number 558/UN6.C1.3.2/KEPK/PN/2015.
The mice used in this study were healthy, male mice
with Wistar strains aged 3-4 months with a weight of
200-300 g. The mice were adapted for a week in the
Biochemistry Laboratory, Faculty of Medicine, Universitas
Padjadjaran. During adaptation, the shelter are cleaned
and mice are gave proper food and water. Mice that died
before the study or during the data collection were not
included in the sample group.
In the study, 24 mice were divided into four groups.
Researcher used Federer’s formula to get the smallest
sample population. The mice were fasted for 8 hours then
given an anesthetic which was intramuscular ketamine 0.4
mL to anesthetized the mice during experiment. Then,
cannulas were inserted 10 cm distally from the pylorus
for the first cannula and 25 cm from the first cannula for
the second cannula. The intestines of the mice were then
cleaned using 0.96% NaCl solution three times.

The comparison in glucose levels for the control group,
200, 400, and 600 mg/kg of the mice weight was presented
in Figure 3. Based on the Shapiro-Wilk data normality
test, it was found that the data distribution of each group
had a significance value of < 0.05 with an interpretation
of normal data distribution. The value of glucose levels
for the control group, 200, 400, and 600 mg/kg mice
weight were chronologically presented in Table 1.
Table 1. Glucose Level in Infusion
Glucose Level in Infusion (mg/dL)
15’
30’
45’
60’
Control

1
2
3
4
5
6

25.397
24.603
40.079
28.571
34.921
29.762
30.556

17.063
23.413
38.889
25.397
31.349
19.841
25.991

13.492
20.238
29.762
21.825
26.190
17.857
21.561

12.302
15.079
20.635
17.857
19.841
15.476
16.865

1
2
3
4
5
6

112.698
113.095
112.698
112.698
135.714
124.603
118.585

111.508
111.111
110.317
109.921
111.508
121.429
112.632

108.730
107.937
108.333
95.635
95.635
120.635
106.151

107.143
106.746
105.556
90.873
88.095
104.762
100.529

1
2
3
4
5
6

142.857
129.365
146.825
142.460
137.302
138.492
139.550

141.270
127.381
119.048
132.937
130.556
120.635
128.637

139.286
118.651
114.286
122.619
129.365
124.603
124.801

119.841
140.476
109.921
102.381
123.810
123.016
119.907

1
2
3
4
5
6

122.619
117.063
121.825
154.365
157.540
146.825
136.706

121.429
115.873
118.651
146.825
150.794
139.683
132.209

120.238
113.492
112.302
142.857
149.206
135.317
128.902

117.460
105.159
110.317
134.524
144.444
132.143
124.008

Mean
200 mg/kg
mice
weight

Mean
400 mg/kg
mice
weight

Mean

The tested solution was flowed through the small
intestine of the mice using a perfusion device for 60
minutes. Sample collection was done every 15 minutes
from the 0 to the 60th minute. Samples were examined
using the Trinder enzymatic method. The data analysis
was done using the Shapiro-Wilk method to check the
data distribution and the one-way Analysis of Variance
(one-way ANOVA) method to calculate the significance
of data.
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600 mg/kg
mice
weight

Mean
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starfruit leaves inhibits the glucose absorption in the
intestinal epithelial cells of mice. The glucose rate of 600
mg/kg infused starfruit leaves during every 15 minutes
had a higher value compared to the control group, 200
and 400 mg/kg infused starfruit leaves. This is caused
by the bigger values of active substances in 600 mg/kg
infused starfruit leaves that led to a bigger intervention
in glucose absorption compared to other groups. The
limitation of this study is that the researcher does not
have definite knowledge about the molecular mechanism
of infused starfruit leaves on glucose transport in the
intestinal epithelial cells of mice.

Conclusions

Figure 3. Glucose Level in Infusion

The conclusion of this study is that the administration of
infused starfruit leaves decreases glucose absorption in
the intestinal epithelial cells of mice with the highest
rate of glucose absorption occurring in the first 15
minutes. The 600 mg/kg infused starfruit leaves had the
highest inhibitory effect on glucose absorption compared
to the control group and other infusions.

Conflict of Interest Statement
Discussion
Based on previous studies, it is known that starfruit
leaves have flavone derivatives that exhibit an effect in
lowering glucose levels.1,15,16 The flavone derivatives
found in starfruit leaves consisted of apigenin-6-C-β-Lfucopyranoside and apigenin-6-C-(2-O-α-L-rhamnopyranosyl)-β-1-fucopyranoside15,16 Based on early studies
about starfruit leaves; it was found that the starfruit leaf
had an effect of reducing blood glucose level and
increasing the entry of glucose into the soleus muscle of
mice.1,14,17 The decreasing of blood glucose level and
increasing of glucose entry into muscles are caused by the
starfruit leaves’ effect towards glucose transportation
and insulin release from β cells of the pancreas.1
Based on Figure 3, there was a gradual decrease in
blood glucose level from minute 0 to minute 60 in every
group that showed that there was glucose absorption
through the intestinal epithelial cells of mice in each
group. In previous studies, there were results from the
administration of starfruit leaves extract that intervened
to decrease the glucose level based on measurements of
mice blood samples.1 The lowest blood glucose level
decrease by infusion was found in the test group with
600 mg/kg infused starfruit leaves. A previous study
also found that the administration of 400 mg/kg starfruit
leaves extract had the most potent effect in lowering the
blood glucose level in mice.1
There is a significant difference between the administration
of infused starfruit leaves and control solution on the
decrease of glucose absorption. Based on that, the infused
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